Medicure (MCUJF) Non-Current Assets (2009 - 2026)
Medicure's (MCUJF) quarterly Non-Current Assets came in at $9.2 million in Q1 2026, down 5.63% year-on-year from $9.8 million in Q1 2025, and down 1.73% quarter-over-quarter from $9.4 million in Q4 2025.
Medicure (MCUJF) Non-Current Assets (2009 - 2026) Analysis & Trends
Medicure's Non-Current Assets history runs 18 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- On a quarterly basis, Non-Current Assets fell 5.63% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $9.2 million, a 5.63% decrease from a year earlier, with the FY2025 full-year figure at $9.3 million, down 7.13% from the prior year.
- Non-Current Assets slipped to $9.2 million in Q1 2026 per MCUJF's latest filing, from $9.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $12.1 million in Q3 2022 and bottomed at $9.0 million in Q2 2024.
- The 5-year median for Non-Current Assets is $10.0 million (2023), against an average of $10.2 million.
- Across the five-year window, Non-Current Assets retreated 16.25% in 2023 and advanced 14.36% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $11.0 million in 2022, then slipped by 14.5% to $9.4 million in 2023, then grew by 4.5% to $9.9 million in 2024, then dropped by 5.06% to $9.4 million in 2025, then fell by 1.73% to $9.2 million in 2026.
- Per Business Quant, the three latest MCUJF Non-Current Assets figures stand at $9.2 million (Q1 2026), $9.4 million (Q4 2025), and $10.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 9.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.20 Mn |
| Dec 31, 2025 | 9.37 Mn |
| Sep 30, 2025 | 10.12 Mn |
| Jun 30, 2025 | 10.34 Mn |
| Mar 31, 2025 | 9.75 Mn |
| Dec 31, 2024 | 9.87 Mn |
| Sep 30, 2024 | 9.05 Mn |
| Jun 30, 2024 | 9.04 Mn |
| Mar 31, 2024 | 9.43 Mn |
| Dec 31, 2023 | 9.44 Mn |
| Sep 30, 2023 | 10.10 Mn |
| Mar 31, 2023 | 10.74 Mn |
| Dec 31, 2022 | 11.04 Mn |
| Sep 30, 2022 | 12.05 Mn |
| Jun 30, 2022 | 11.93 Mn |
| Mar 31, 2022 | 11.98 Mn |
| Dec 31, 2021 | 12.58 Mn |
| Sep 30, 2021 | 12.93 Mn |
| Jun 30, 2021 | 13.46 Mn |
| Mar 31, 2021 | 13.65 Mn |